PURPLE - Primary hyperparathyroidism as per NICE NG132. Prescribing pre 1st April 2013 may continue in primary care under previous arrangements
RED - Secondary hyperparathyroidism as per NICE TA117 Prescribing pre 1st April 2013 may continue in primary care under previous arrangements
Mimpara is the preferred option for prescribing
| Pack |
|---|
| 28 tablet |
| Pack |
|---|
| 28 tablet |
| Pack |
|---|
| 28 tablet |
Parsabiv is a branded option commissioned for prescribing.
| Pack |
|---|
| 6 vial |
| Pack |
|---|
| 6 vial |
| Pack |
|---|
| 6 vial |